I
OGN icon

INVST’s Organon & Co OGN Stock Holding History

INVST’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,054
Closed -$66.2K – 358
2026
Q1 		$66.2K Sell
11,054
-796
-7% -$5.99K 0.01% 327
2025
Q4 		$85K Buy
+11,850
New +$93.6K 0.01% 303

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

INVST's OGN Position: Q2 2026 in Review

INVST sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 11,054 shares — an estimated $66.2K sold.

INVST first reported a position in OGN in Q4 2025 and held it in 2 quarters. The position peaked at $85K in Q4 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • INVST reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • INVST sold 11,054 Organon & Co shares in Q2 2026, an estimated $66.2K.
  • INVST first reported a position in Organon & Co in Q4 2025 and held it in 2 quarters.
  • INVST's Organon & Co position peaked at $85K in Q4 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.